Skip to main content

Prostate cancer screening.

Publication ,  Chapter
Ragsdale, JW; Halstater, B; Martinez-Bianchi, V
June 2014

Universal screening for prostate cancer (Pca) using prostate-specific antigen-based testing is not recommended, as the potential harms of screening (overdiagnosis and overtreatment) outweigh potential benefits. The case for Pca screening requires a paradigm shift, which emphasizes the risks of screening over the risks of undetected cancer. Physicians are encouraged to use shared decision making with patients who express an interest in Pca screening, taking into account both the patient's screening preferences and individual risk profile. New models of care informed by the Patient Protection and Affordable Care Act are intended to assist clinicians in providing recommended preventive services.

Duke Scholars

DOI

Publication Date

June 2014

Volume

41

Start / End Page

355 / 370

Related Subject Headings

  • Risk Factors
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Primary Health Care
  • Practice Guidelines as Topic
  • Patient Participation
  • Male
  • Humans
  • General & Internal Medicine
  • Early Detection of Cancer
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ragsdale, J. W., Halstater, B., & Martinez-Bianchi, V. (2014). Prostate cancer screening. (Vol. 41, pp. 355–370). https://doi.org/10.1016/j.pop.2014.02.009
Ragsdale, John W., Brian Halstater, and Viviana Martinez-Bianchi. “Prostate cancer screening.,” 41:355–70, 2014. https://doi.org/10.1016/j.pop.2014.02.009.
Ragsdale JW, Halstater B, Martinez-Bianchi V. Prostate cancer screening. In 2014. p. 355–70.
Ragsdale, John W., et al. Prostate cancer screening. Vol. 41, 2014, pp. 355–70. Pubmed, doi:10.1016/j.pop.2014.02.009.
Ragsdale JW, Halstater B, Martinez-Bianchi V. Prostate cancer screening. 2014. p. 355–370.

DOI

Publication Date

June 2014

Volume

41

Start / End Page

355 / 370

Related Subject Headings

  • Risk Factors
  • Prostatic Neoplasms
  • Prostate-Specific Antigen
  • Primary Health Care
  • Practice Guidelines as Topic
  • Patient Participation
  • Male
  • Humans
  • General & Internal Medicine
  • Early Detection of Cancer